Free Trial

Alnylam Pharmaceuticals (ALNY) Insider Trading & Ownership

$236.69
-0.01 (0.00%)
(As of 10:40 AM ET)

Alnylam Pharmaceuticals (NASDAQ:ALNY) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
1.50%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
7
Amount Of
Insider Selling
(Last 12 Months)
$23.94 M
Get ALNY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Alnylam Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ALNY Insider Buying and Selling by Quarter

Alnylam Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.00  
6/25/2024Jeffrey V PoultonCFOSell1,605$231.00$370,755.00  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.02  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.97  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.99  
6/24/2024David E I PyottDirectorSell32,450$220.69$7,161,390.50  
5/29/2024Amy W SchulmanDirectorSell21,700$148.60$3,224,620.00  
1/29/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$180.96$1,001 - $15,000
1/11/2024Josh GottheimerU.S. Congress Member (D-NJ)Buy$195.08$1,001 - $15,000
12/27/2023Michael W BonneyDirectorSell30,000$195.00$5,850,000.00  
12/11/2023Josh GottheimerU.S. Congress Member (D-NJ)Sell$170.92$1,001 - $15,000
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.74  
8/4/2023Jeffrey V PoultonCFOSell3,460$185.85$643,041.00  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.85  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.45  
(Data available from 1/1/2013 forward)

ALNY Insider Trading Activity - Frequently Asked Questions

What percentage of Alnylam Pharmaceuticals stock is owned by insiders?

1.50% of Alnylam Pharmaceuticals stock is owned by insiders. Learn more on ALNY's insider holdings.

Which Alnylam Pharmaceuticals insiders have been selling company stock?

The following insiders have sold ALNY shares in the last 24 months: Akshay Vaishnaw ($465,459.28), Amy W Schulman ($3,224,620.00), David E I Pyott ($7,161,390.50), Indrani Lall Franchini ($1,113,566.75), Jeffrey V Poulton ($1,203,910.43), Kevin Joseph Fitzgerald ($276,726.02), Michael W Bonney ($5,850,000.00), Pushkal Garg ($5,867,335.57), Tolga Tanguler ($1,057,187.40), and Yvonne Greenstreet ($6,004,517.29).

How much insider selling is happening at Alnylam Pharmaceuticals?

Insiders have sold a total of 160,735 Alnylam Pharmaceuticals shares in the last 24 months for a total of $32,224,713.24 sold.

Which members of congress are trading Alnylam Pharmaceuticals?

Josh Gottheimer (D-NJ) has bought shares of Alnylam Pharmaceuticals in the last year totaling $8,000. Josh Gottheimer (D-NJ) has sold shares totaling $16,000.


This page (NASDAQ:ALNY) was last updated on 7/19/2024 by MarketBeat.com Staff

From Our Partners